NCT04508998View on ClinicalTrials.gov

PRIZE ET Sub-Study

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

May 14, 2021

Primary Completion Date

August 13, 2022

Study Completion Date

August 13, 2022

Conditions
Microvascular Angina
Interventions
DIAGNOSTIC_TEST

Blood tests including genotyping

Blood tests for alternative SNPs altering levels of ET-A receptor expression; blood will be further analysed for endothelin receptor mRNA and other plasma peptides important in the endothelin signalling pathway

DIAGNOSTIC_TEST

Exercise Tolerance Test

Treadmill exercise test using the Bruce protocol

Trial Locations (1)

CB2 0AY

Royal Papworth Hospital NHS Foundation Trust, Cambridge

All Listed Sponsors
collaborator

NHS Greater Glasgow and Clyde

OTHER

lead

Papworth Hospital NHS Foundation Trust

OTHER_GOV